OptiCell Solutions – A Key Player in Cell and Gene Therapy Establishes in Flemingsberg

Flemingsberg continues to be a natural choice for knowledge-intensive and innovative businesses. OptiCell Solutions is a company that recently launched its operations at Novum Labs on Campus Flemingsberg. Founded in 2024 by specialists from Karolinska University Hospital and entrepreneurs from the Life Science industry, the company specializes in improving the availability of high-quality target cells for cell and gene therapies, a critical component of the growing ATMP (Advanced Therapy Medicinal Products) sector.

Collecting High-Quality Target Cells – A Bottleneck
“Rapid access to high-quality cells can save lives,” says Jarmo Henriksson, CEO and the visionary founder of the newly established company OptiCell Solutions. Using advanced apheresis technology*, OptiCell Solutions enables the collection of cells from voluntary study participants, cell donors, and patients without delays.

“We aim to enhance access to new treatment options for patients with chronic diseases, offering our services to biotech companies, pharmaceutical companies, medical technology firms, CROs, and healthcare providers,” explains Jarmo Henriksson.

Flemingsberg – A Strategic Choice
OptiCell Solutions has chosen Flemingsberg as the base for its operations, a hub for innovation in Life Science and a growing ATMP cluster. Located near the Karolinska ATMP Center and Karolinska University Hospital, and within the flexible laboratory hotel Novum Labs, the company benefits from proximity to leading research and healthcare institutions.

“This geographical location supports the company’s vision of simplifying cell collection and accelerating the development of cell and gene therapies.”

Patient-Centered and Efficient Approach
OptiCell Solutions’ technology, called leukapheresis, enables the gentle and efficient collection of necessary cells. This method can yield at least 20 times more target cells compared to standard blood donations, while returning the blood to the donor for increased safety.

“At OptiCell Solutions, we prioritize creating a safe and comfortable environment for cell donors. With our apheresis technology, bright facilities, and comfortable treatment chairs, we ensure high-quality cell materials while providing a positive experience for donors,” says Jarmo Henriksson.

What Are Your Future Goals?

“OptiCell Solutions’ long-term goal is to become a leading player in cell collection for cell and gene therapies. We see great potential in Flemingsberg as a future center for innovation and collaboration within Life Science,” says Jarmo.

Finally, Jarmo shares that OptiCell Solutions also envisions supporting the development of precision medicine by ensuring access to high-quality target cells across Europe, a crucial factor for the success of biological drugs and innovative treatments.

*Apheresis technology involves separating blood into its components using centrifugation during ongoing leukapheresis.

Taking the leap as a solo developer in Sweden’s growing game industry

Jacques Diringer left a secure job at the game giant King to follow his dream of creating his own game from scratch. In a Stockholm where the gaming industry is growing rapidly and new companies are launched every year, he now embarks on a more uncertain but creative journey. The path has been both challenging and inspiring, shaped by a vibrant gaming community, new collaborations, and the courage to trade stability for freedom.

Steps shaping innovation and growth – Natasha Bank sums up the first year of Life Science Cluster Flemingsberg

A future life science cluster isn’t built in a year – but with a solid foundation and the courage to act, important steps can be taken along the way. In February 2025, we launched Life Science Cluster Flemingsberg: a multifaceted project with powerful, interconnected ambitions – to enable Flemingsberg’s life science cluster to reach its full potential by collaboration and creating the right conditions for the establishment and growth of those who drive innovation – small and medium-sized enterprises – and, in doing so, contribute to the Stockholm region’s leading position within the sector.

Johnny Högberg Summarizes 2025 – A Year of Growth and Collaboration in Flemingsberg

We are most effective and make the greatest impact when we engage our founders and leverage their size, organizations, and influence, and we still strongly believe in this. At the same time, the fact that we have grown as an organization has also made a difference. Today, we are exactly the kind of “two-pizza team” that Amazon founder Jeff Bezos highlights as the most effective. Among other things, we are now running two cluster initiatives and creating a level of engagement, buzz, and content that is noticeable in Flemingsberg and is actually helping to change the area.

Go to Top